Published in J Clin Sleep Med on October 15, 2015
Effect of Light and Melatonin and Other Melatonin Receptor Agonists on Human Circadian Physiology. Sleep Med Clin (2015) 0.79
Prevalence of Circadian Rhythm Sleep-Wake Disorders and Associated Factors in Euthymic Patients with Bipolar Disorder. PLoS One (2016) 0.79
Circadian-Based Therapies for Circadian Rhythm Sleep-Wake Disorders. Curr Sleep Med Rep (2016) 0.78
Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders. Pharmacotherapy (2016) 0.78
Do Evidence-Based Treatments for Circadian Rhythm Sleep-Wake Disorders Make the GRADE? Updated Guidelines Point to Need for More Clinical Research. J Clin Sleep Med (2015) 0.76
How Did It Get Late So Soon? J Clin Sleep Med (2016) 0.75
Quality Control of Over-the-Counter Melatonin Poor: What They Say Is Often Not What You Get. J Clin Sleep Med (2017) 0.75
Blood transcriptome based biomarkers for human circadian phase. Elife (2017) 0.75
Overview of Common Sleep Disorders and Intersection with Dermatologic Conditions. Int J Mol Sci (2016) 0.75
Non-24-Hour Sleep-Wake Disorder Revisited - A Case Study. Front Neurol (2016) 0.75
Updated clinical guidelines experience major reporting limitations. Implement Sci (2017) 0.75
Sleep and circadian variability in people with delayed sleep-wake phase disorder versus healthy controls. Sleep Med (2017) 0.75
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77
GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02
A two process model of sleep regulation. Hum Neurobiol (1982) 9.11
Stability, precision, and near-24-hour period of the human circadian pacemaker. Science (1999) 7.74
Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron (1995) 5.70
Transplanted suprachiasmatic nucleus determines circadian period. Science (1990) 5.55
Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med (2009) 5.36
GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol (2011) 5.10
Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci U S A (1972) 4.65
Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res (1972) 4.58
Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol (2000) 4.39
Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci (2001) 4.36
GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54
Light suppresses melatonin secretion in humans. Science (1980) 3.45
GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol (2011) 3.44
Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep (2007) 3.38
An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol (2001) 3.34
GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 3.30
Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med (1995) 3.08
GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol (2011) 3.02
Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med (2013) 2.93
GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol (2011) 2.83
Sleep, circadian rhythms, and delayed phase in adolescence. Sleep Med (2007) 2.76
Homeostatic sleep regulation in adolescents. Sleep (2005) 2.75
Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med (2000) 2.63
The treatment of early-morning awakening insomnia with 2 evenings of bright light. Sleep (2005) 2.36
Patterns of sleep and sleepiness in adolescents. Pediatrician (1990) 2.28
Impact of delaying school start time on adolescent sleep, mood, and behavior. Arch Pediatr Adolesc Med (2010) 2.22
The treatment of sleep disorders with melatonin. Dev Med Child Neurol (1994) 2.18
The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res (2002) 2.18
The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med (2007) 2.16
Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep (2005) 2.09
Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA (2008) 2.07
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction (2003) 2.06
Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep (2007) 2.05
Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev (2002) 1.86
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet (2008) 1.72
Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry (1997) 1.71
Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance. J Appl Physiol (1985) (2011) 1.68
Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord (2011) 1.66
Complementary medicines in psychiatry: review of effectiveness and safety. Br J Psychiatry (2006) 1.61
Antidepressant action of melatonin in the treatment of Delayed Sleep Phase Syndrome. Sleep Med (2009) 1.60
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep (2003) 1.58
Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial. J Am Geriatr Soc (2005) 1.57
Adolescent sleep, school start times, and teen motor vehicle crashes. J Clin Sleep Med (2008) 1.55
Melatonin administration alters semen quality in healthy men. J Androl (2002) 1.54
The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med (2005) 1.54
Phase advancing the human circadian clock with blue-enriched polychromatic light. Sleep Med (2008) 1.53
Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc (2002) 1.53
Potential safety issues in the use of the hormone melatonin in paediatrics. J Paediatr Child Health (2015) 1.49
Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav Sleep Med (2003) 1.47
Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet (2015) 1.45
Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol (2000) 1.43
Light therapy for non-seasonal depression. Cochrane Database Syst Rev (2004) 1.43
Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr (2005) 1.42
Low, but not high, doses of melatonin entrained a free-running blind person with a long circadian period. Chronobiol Int (2002) 1.39
Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. Am J Psychiatry (1992) 1.38
Phase delaying the human circadian clock with blue-enriched polychromatic light. Chronobiol Int (2009) 1.35
Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand (1994) 1.33
Delayed sleep phase syndrome response to melatonin. Lancet (1991) 1.33
Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial. J Am Geriatr Soc (2011) 1.32
Photic resetting of the human circadian pacemaker in the absence of conscious vision. J Biol Rhythms (2002) 1.31
Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry (2007) 1.29
Modifications to weekend recovery sleep delay circadian phase in older adolescents. Chronobiol Int (2010) 1.28
Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J Clin Endocrinol Metab (1992) 1.27
The human circadian system adapts to prior photic history. J Physiol (2011) 1.27
Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome. Sleep (1990) 1.25
Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab (2010) 1.24
Human phase response curve to a 1 h pulse of bright white light. J Physiol (2012) 1.23
Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc (1993) 1.23
Nonphotic entrainment of the human circadian pacemaker. Am J Physiol (1998) 1.23
Randomized, controlled trial of a nonpharmacological intervention to improve abnormal sleep/wake patterns in nursing home residents. J Am Geriatr Soc (2005) 1.23
Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc (2007) 1.22
Daytime naps in darkness phase shift the human circadian rhythms of melatonin and thyrotropin secretion. Am J Physiol Regul Integr Comp Physiol (2000) 1.20
Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light. J Clin Endocrinol Metab (2005) 1.20
Is sleep per se a zeitgeber in humans? J Biol Rhythms (2003) 1.15
A late wake time phase delays the human dim light melatonin rhythm. Neurosci Lett (2005) 1.14
Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry (2002) 1.14
Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia. Sleep (1981) 1.14
Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease. Int Psychogeriatr (2005) 1.14
A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res (2008) 1.14
A practical approach to circadian rhythm sleep disorders. Sleep Med Rev (2008) 1.12
Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol (1998) 1.12
Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res (2009) 1.11
The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. J Biol Rhythms (2003) 1.11
Synchronisation of a disturbed sleep-wake cycle in a blind man by melatonin treatment. Lancet (1988) 1.10
Effects of an advanced sleep schedule and morning short wavelength light exposure on circadian phase in young adults with late sleep schedules. Sleep Med (2011) 1.09
Prolonged interval from body temperature nadir to sleep offset in patients with delayed sleep phase syndrome. Sleep (1996) 1.09
Human responses to bright light of different durations. J Physiol (2012) 1.08
Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res (2000) 1.08
Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol (2001) 1.08
Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin. Brain Res (2001) 1.07
Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. J Clin Sleep Med (2008) 1.05
Lack of short-wavelength light during the school day delays dim light melatonin onset (DLMO) in middle school students. Neuro Endocrinol Lett (2010) 1.03
Melatonin entrains free-running blind people according to a physiological dose-response curve. Chronobiol Int (2005) 1.03
Altered phase relation between sleep timing and core body temperature rhythm in delayed sleep phase syndrome and non-24-hour sleep-wake syndrome in humans. Neurosci Lett (2000) 1.03
Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One (2013) 1.02
Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase. Am J Physiol Regul Integr Comp Physiol (2003) 1.02
Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. J Clin Sleep Med (2015) 1.12
Quality measures for the care of adult patients with obstructive sleep apnea. J Clin Sleep Med (2015) 1.06
Measurement of quality to improve care in sleep medicine. J Clin Sleep Med (2015) 1.05
Quality measures for the care of pediatric patients with obstructive sleep apnea. J Clin Sleep Med (2015) 0.89
Development of the National Healthy Sleep Awareness Project Sleep Health Surveillance Questions. J Clin Sleep Med (2015) 0.81
Do Evidence-Based Treatments for Circadian Rhythm Sleep-Wake Disorders Make the GRADE? Updated Guidelines Point to Need for More Clinical Research. J Clin Sleep Med (2015) 0.76
Capitulation or advocacy for sleep physicians and patients? J Clin Sleep Med (2014) 0.75
The Evolution of the AASM Clinical Practice Guidelines: Another Step Forward. J Clin Sleep Med (2016) 0.75